Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NATCO PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    NATCO PHARMA
Mar-23
ADCOCK INGRAM
Jun-14
NATCO PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs847320-   
Low Rs502231-   
Sales per share (Unadj.) Rs148.495.1-  
Earnings per share (Unadj.) Rs39.2-24.0-  
Cash flow per share (Unadj.) Rs48.2-19.9-  
Dividends per share (Unadj.) Rs5.500-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs267.174.6-  
Shares outstanding (eoy) m182.47168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.52.9 157.1%   
Avg P/E ratio x17.2-11.5 -149.8%  
P/CF ratio (eoy) x14.0-13.9 -101.0%  
Price / Book Value ratio x2.53.7 68.5%  
Dividend payout %14.00-   
Avg Mkt Cap Rs m123,04946,446 264.9%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m4,8672,915 167.0%   
Avg. sales/employee Rs Th03,739.2-  
Avg. wages/employee Rs Th0679.0-  
Avg. net profit/employee Rs Th0-942.2-  
INCOME DATA
Net Sales Rs m27,07116,052 168.6%  
Other income Rs m1,285112 1,143.1%   
Total revenues Rs m28,35616,165 175.4%   
Gross profit Rs m9,117-2,782 -327.7%  
Depreciation Rs m1,638693 236.4%   
Interest Rs m145435 33.3%   
Profit before tax Rs m8,619-3,797 -227.0%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,466237 617.9%   
Profit after tax Rs m7,153-4,045 -176.8%  
Gross profit margin %33.7-17.3 -194.3%  
Effective tax rate %17.0-6.2 -272.2%   
Net profit margin %26.4-25.2 -104.9%  
BALANCE SHEET DATA
Current assets Rs m30,00311,757 255.2%   
Current liabilities Rs m6,8316,615 103.3%   
Net working cap to sales %85.632.0 267.2%  
Current ratio x4.41.8 247.1%  
Inventory Days Days63111 57.2%  
Debtors Days Days115124 93.1%  
Net fixed assets Rs m26,5716,853 387.7%   
Share capital Rs m36575 489.7%   
"Free" reserves Rs m48,3730-   
Net worth Rs m48,73812,599 386.8%   
Long term debt Rs m04,428 0.0%   
Total assets Rs m56,57423,801 237.7%  
Interest coverage x60.4-7.7 -781.7%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.50.7 70.9%   
Return on assets %12.9-15.2 -85.1%  
Return on equity %14.7-32.1 -45.7%  
Return on capital %18.0-19.8 -90.8%  
Exports to sales %00-   
Imports to sales %10.20-   
Net fx Rs m14,4840-   
CASH FLOW
From Operations Rs m8,4911,370 619.7%  
From Investments Rs m-4,771-421 1,134.0%  
From Financial Activity Rs m-3,6304,018 -90.3%  
Net Cashflow Rs m2084,968 4.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.41 Rs / ZAR

Compare NATCO PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare NATCO PHARMA With: CONCORD BIOTECH  ADVIK LABORS  SURYA PHARMA  AUROBINDO PHARMA  EVEREST ORGANICS  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.